In May, the U.S. Preventative Services Task Force issued a document that recommended against routine PSA screening for prostate cancer (PCa).

It based that recommendation on its conclusion, based on a review of scientific evidence, that there is “moderate or high certainty that the service has no net benefit or that the harms outweigh the benefit.”

Although some men may benefit from having PCa detected early through PSA screening, the task force contends there is no conclusive evidence that routine PSA screening save lives, and noted that false-positive PSA test results can cause psychological harm and lead to prostate biopsies, which can cause discomfort.

Continue Reading

Renal & Urology News would like to know how the task force’s recommendation has affected urologists’ practices, so please answer the following poll question: